Challenges associated with long-term therapies in CLL
Are prognostic factors the key to precision medicine in CLL?
ASH: setting the scene for new standards of care
Can we apply knowledge on CLL to other types of cancers?
Current research on CD19 targeted CAR T-cells in relapsed B-cell ALL